< Back to previous page

Researcher

Frederik Verelst

  • Research interest:Frederik Verelst is a postdoctoral health economics researcher at the Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID) at the University of Antwerp. His work focusses on incorporating prevention behavior in models for infectious disease dynamics, assessing societal preferences with respect to vaccination, the economic evaluation of vaccination programs, the macroeconomic impact of public health emergencies of international concern (e.g. SARS-CoV-2) and the determinants of vaccination coverage. Frederik has extensive experience in the design and analysis of survey instruments, and in particular in discrete-choice experiments (DCEs) that aim to quantify preferences of the general population. He has contributed to several research projects, including projects on the transmission of and/or the economic evaluation of interventions for measles, influenza, RSV, rotavirus, TB, SARS-CoV-2, herpes zoster, epilepsy and integrated maternity care.
  • Keywords:EPIDEMIOLOGY, HEALTH ECONOMICS, VACCINATION, PREVENTION, PHARMACOECONOMICS, MODELLING, INFECTIOUS DISEASES, ECONOMIC EVALUATION, Economics and applied economics
  • Disciplines:Applied economics, Macroeconomics and monetary economics, Mathematical and quantitative methods, Microeconomics, Other economics and business, Other social sciences, Vaccinology, Infectious diseases, Health care financing, Health economy, Health promotion and policy, Preventive medicine, Epidemiology, Pharmaco-economics, Pharmaco-epidemiology, Health, education and welfare economics
  • Research techniques:Health Technology Assessment (HTA), Health Economic Evaluation, Cost-Effectiveness Analysis, Cost-Benefit Analysis, Cost-Utility Analysis, Modelling Infectious Diseases, Economic evaluation of infectious disease prevention programmes, Discrete-Choice Experiments (DCE), attitudinal survey techniques
  • Users of research expertise:Stakeholders interested in the health economic evaluation and/or modelling of infectious disease interventions.